1.https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2023 2.https://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/2023-biological-license-application-approvals 3.https://www.fda.gov/media/1752...
31.https://go.drugbank.com/drugs/DB14919 32.https://go.drugbank.com/drugs/DB18704 33.https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approvals-talvey-talquetamab-tgvs-relapsed-or-refractory-multiple 34.ht...
31.https://go.drugbank.com/drugs/DB14919 32.https://go.drugbank.com/drugs/DB18704 33.https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approvals-talvey-talquetamab-tgvs-relapsed-or-refractory-multiple 34.https://go.drugbank.com/drugs/DB15766 35.h...
New Study: FDA Approved Drugs are Dangerous - Waking Timesdugs
The FDA approved Beyfortus, from AstraZeneca and Sanofi, to protect infants from the respiratory virus RSV. AstraZeneca and Sanofi Until recently, parents and doctors only had one option to shield some babies from RSV: monthly injections of palivizumab, an antibody drug which is recommended for...
Now, the Food and Drug Administration(FDA) has approved two drugs that may slow the cognitive decline destroying the lives of millions of Alzheimer’s patients. But both approvals are highly controversial. They were only based on the drugs’ ability to remove plaques (斑块), which were thought...
The FDA in 2011 announced years' worth of studies from a major drug research lab were potentially worthless, but it has not pulled any of the compounds from the market nor identified them
ADC drugs need to go through multiple steps to take effect after entering the body, and each step has technical difficulties that need to be overcome. As of November 2022, the FDA has approved 14 different ADCs, including Lumoxiti (moxetumomab pasudotox-tdfk), which we consider an ...
Ahead of us in June,it is anticipated FDA will make decisions on the following four drugs. Drug: spesolimab Company: Boehringer Ingelheim Indication: generalized pustular psoriasis Boehringer Ingelheim’s spesolimab is a humanized, selective antib...
These stimulants are controlled substances approved for short-term use in weight loss, usually only up to 12 weeks maximum. As with other weight loss treatments, these drugs should be used in conjunction with ongoing diet and exercise to maintain weight loss....